NTRK1 and breast carcinoma: The use of anti-phospho-TrkA antibodies demonstrated that only the 180 kDa form of TrkA is tyrosine phosphorylated in breast cancer cells, as no phospho-TrkA band could be detected at 140 kDa (Figure 3).